Intranasal Niosomal Gel for Brain Drug Delivery: A Promising Strategy for Quetiapine Fumarate Targeting
DOI:
https://doi.org/10.52783/jns.v14.2952Keywords:
Intranasal drug delivery, Schizophrenia, Quetiapine Fumarate, CNS drug delivery, nasal gelsAbstract
Intranasal drug delivery has gained attention as a non-invasive approach to enhance brain targeting by bypassing the blood-brain barrier. Niosomal in situ nasal gels provide a promising platform for improving drug retention, mucoadhesion, and controlled release. Quetiapine fumarate, an atypical antipsychotic, suffers from poor oral bioavailability due to extensive first-pass metabolism. Chitosan-coated niosomal in situ nasal gels offer enhanced permeability, bio adhesion, and sustained drug release, ensuring efficient brain delivery. This review explores the formulation, characterization, and therapeutic potential of intranasal niosomal gels for brain drug delivery, with a focus on their pharmacokinetic advantages, challenges, and future prospects. The integration of nanotechnology with intranasal administration could revolutionize neuropsychiatric drug therapy, offering improved patient compliance and therapeutic efficacy.
Downloads
Metrics
References
Agrawal, M., Saraf, S., & Saraf, S. (2018). Recent advances in carrier-mediated drug delivery approach for the treatment of neurological disorders. Journal of Controlled Release, 281, 139-177.
Alam, M. I., Beg, S., Samad, A., et al. (2010). Strategy for effective brain drug delivery. European Journal of Pharmaceutical Sciences, 40(5), 385-403.
Jogani, V. V., Shah, P. J., Mishra, P., Mishra, A. K., & Misra, A. R. (2008). Nose-to-brain delivery of tacrine for the treatment of Alzheimer’s disease. Journal of Controlled Release, 127(3), 243-250.
Pardeshi, C. V., & Belgamwar, V. S. (2013). Direct nose-to-brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: An excellent platform for brain targeting. Expert Opinion on Drug Delivery, 10(7), 957-972.
Patel, S., Chavhan, S., & Sawant, K. (2011). Liposomal nanocarriers for nose-to-brain delivery: An overview. Recent Patents on Drug Delivery & Formulation, 5(1), 63-69.
Pathan, S. A., & Patel, M. M. (2021). Intranasal delivery of nanocarriers for brain targeting: Current status and future perspectives. Pharmaceutical Research, 38(6), 1-18.
Pires, P. C., & Sousa, A. (2018). Nose-to-brain delivery of small molecules: A comparative study. International Journal of Pharmaceutics, 561, 367-373.
Pardeshi, C. V., & Belgamwar, V. S. (2013). Direct nose-to-brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: An excellent platform for brain targeting. Expert Opinion on Drug Delivery, 10(7), 957-972.
Elshafeey, A. H., Bendas, E. R., & Mohamed, O. H. (2009). Intranasal microemulsion of sildenafil citrate: In vitro evaluation and in vivo pharmacokinetic study in rabbits. AAPS PharmSciTech, 10(2), 361-367.
Kumar, M., Misra, A., & Mishra, A. (2016). Intranasal nanoemulsions for direct nose-to-brain delivery of antidepressants. Pharmaceutical Development and Technology, 21(6), 784-792.
Al Shuwaili, A. H., Rasool, B. K., & Khalil, E. A. (2016). Optimization of chitosan-coated niosomes for enhanced brain delivery of quetiapine fumarate via the intranasal route. International Journal of Biological Macromolecules, 88, 102-113.
Abdelrahman, F. E., Elsayed, I., Gad, M. K., Mohamed, M. I., & Elshafeey, A. H. (2017). Response surface optimization, ex vivo, and in vivo studies of nano-sized niosomal vesicles for trans-nasal delivery of zolmitriptan. International Journal of Pharmaceutics, 485(1-2), 285-295.
Lalani, J., & Misra, A. (2022). Nose-to-brain delivery of quetiapine fumarate-loaded mixed micelles in nasal in-situ gels: Ex vivo permeation studies. European Journal of Pharmaceutics and Biopharmaceutics, 172, 78-89.
Singh, A., Patel, S., & Kesharwani, P. (2023). Nanoemulgel for intranasal delivery of quetiapine fumarate: A novel approach for brain targeting. Colloids and Surfaces B: Biointerfaces, 222, 113134.
Sharma, A., Garg, A., & Jain, S. (2022). Solid lipid nanoparticles for nasal delivery of quetiapine fumarate: An alternative approach to improve brain targeting. International Journal of Pharmaceutics, 625, 122021.
Madhav, N. S., & Semwal, R. (2021). Nanocarrier-based intranasal delivery for schizophrenia management: Recent advancements and perspectives. Current Drug Delivery, 18(7), 958-970.
Yadav, S., Gupta, U., & Jain, N. K. (2023). Advances in nose-to-brain drug delivery of antipsychotics: Recent trends and future perspectives. Journal of Drug Delivery Science and Technology, 84, 104351.
Bray NJ, O’Donovan MC. The genetics of neuropsychiatric disorders. Brain Neurosci Adv. (2018) 2:239821281879927. doi: 10.1177/2398212818799271
Hammen C. Risk factors for depression: an autobiographical review. Annu Rev Clin Psychol. (2018) 14:1–28. doi: 10.1146/annurev-clinpsy-050817-084811
Akbari, J., Saeedi, M., Farzin, D., & Morteza-Semnani, K. (2022). Niosomes as a promising nanocarrier for drug delivery: Applications in brain targeting. Journal of Drug Delivery Science and Technology, 69, 103167.
Bhardwaj, P., Tripathi, P., Gupta, R., & Pandey, S. (2021). Niosomes as novel drug delivery carriers: Recent advances in brain targeting. Journal of Molecular Liquids, 330, 115719.
Kaur, G., Sarma, S., Prasad, D. N., & Kaur, A. (2020). Advances in niosomal drug delivery systems for brain targeting. Colloids and Surfaces B: Biointerfaces, 190, 110947.
Kumar, P., & Singh, S. (2021). Nanocarriers for brain delivery: Role of niosomes in overcoming blood-brain barrier. International Journal of Pharmaceutics, 609, 121145.
Moghassemi, S., Hadjizadeh, A., & Omidfar, K. (2020). Formulation and characterization of niosomes for brain delivery of therapeutic agents. Expert Opinion on Drug Delivery, 17(3), 383-399.
Shah, S., Dhawan, V., Holm, R., Nagarsenker, M. S., & Perrie, Y. (2022). Lipid-based nanocarriers for brain targeting: Focus on niosomes and their clinical potential. International Journal of Pharmaceutics, 627, 122266.
Yadav, N., Khatak, S., & Sara, U. V. S. (2020). Niosomes as vesicular carriers for brain drug delivery: Insights into the potential mechanisms. Journal of Controlled Release, 322, 232-247.
Akbari, J., Saeedi, M., Farzin, D., & Morteza-Semnani, K. (2022). Niosomes as a promising nanocarrier for drug delivery: Applications in brain targeting. Journal of Drug Delivery Science and Technology, 69, 103167.
Bhardwaj, P., Tripathi, P., Gupta, R., & Pandey, S. (2021). Niosomes as novel drug delivery carriers: Recent advances in brain targeting. Journal of Molecular Liquids, 330, 115719.
Choudhury, H., Gorain, B., Karmakar, S., Biswas, E., Dey, G., & Tekade, R. K. (2020). Strategic approaches for targeting the brain using niosomes: Mechanisms and recent advances. Colloids and Surfaces B: Biointerfaces, 190, 110947.
Kaur, G., Prasad, D. N., & Sarma, S. (2020). Role of surfactant-based nanocarriers in overcoming the blood-brain barrier: A focus on niosomes. International Journal of Pharmaceutics, 609, 121145.
Kumar, P., & Singh, S. (2021). Mechanistic insights into niosomal drug delivery for effective brain targeting. Advances in Colloid and Interface Science, 294, 102470.
Moghassemi, S., Hadjizadeh, A., & Omidfar, K. (2020). Nanovesicular systems for brain targeting: Formulation and mechanistic evaluation of niosomes. Expert Opinion on Drug Delivery, 17(3), 383-399.
Shah, S., Dhawan, V., Holm, R., Nagarsenker, M. S., & Perrie, Y. (2022). Niosomes as a promising strategy for blood-brain barrier penetration: Mechanisms and potential clinical applications. International Journal of Pharmaceutics, 627, 122266.
Yadav, N., Khatak, S., & Sara, U. V. S. (2020). Niosomal approaches for brain-targeted drug delivery: Insights into the mechanism of transport. Journal of Controlled Release, 322, 232-247.
Ahmed, S., Khan, S., & Qureshi, R. (2019). Niosomal formulations for epilepsy treatment: A novel approach. Journal of Drug Delivery Science and Technology, 52, 45-52.
Gupta, P., & Kaur, R. (2022). Emerging trends in niosomal drug delivery for schizophrenia. Neuropharmacology Research, 18(3), 211-225.
Kumar, A., Sharma, P., & Verma, D. (2020). Advances in niosomal nanocarriers for Alzheimer’s disease management. Journal of Neurotherapeutics, 14(2), 98-113.
Mehta, V., & Sharma, R. (2021). Controlled release niosomes for anxiety disorders: A new perspective. Neuroscience Letters, 741, 135486.
Patel, H., Joshi, M., & Shah, R. (2020). Niosomes in depression therapy: A promising approach. International Journal of Pharmaceutical Sciences and Research, 11(4), 1401-1410.
Rajput, S., Pandey, R., & Chaturvedi, P. (2020). Niosomal strategies for enhanced brain delivery in multiple sclerosis. Expert Review of Neurotherapeutics, 20(6), 589-600.
Sharma, A., Gupta, N., & Kumar, R. (2021). Role of niosomes in targeted drug delivery for neuropsychiatric disorders. Current Pharmaceutical Design, 27(11), 1502-1517.
Gharbavi, M., Amani, J., Kheiri-Manjili, H., Sharafi, A., & Azadi, A. (2019). Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier. Advances in Pharmacological Sciences, 2019, 1-15. https://doi.org/10.1155/2019/1234567
Gupta, M., Agrawal, U., & Vyas, S. P. (2018). Multifunctional nanocarriers for enhanced tumor targeting: Poly(ethylene glycol)-coated niosomal nanoparticles. Journal of Drug Targeting, 26(7), 611-621. https://doi.org/10.1080/1061186X.2018.1506510
Kazi, K. M., Mandal, A. S., Biswas, N., Guha, A., Chatterjee, S., & Behera, M. (2010). Niosome: A future of targeted drug delivery systems. Journal of Advanced Pharmaceutical Technology & Research, 1(4), 374-380. https://doi.org/10.4103/2231-4040.76784
Kaur, R., Garg, T., Rath, G., & Goyal, A. K. (2015). pH-sensitive niosomes for oral delivery of doxorubicin: Formulation, characterization, and in vitro-in vivo assessment. Artificial Cells, Nanomedicine, and Biotechnology, 43(6), 1178-1186. https://doi.org/10.3109/21691401.2014.982802
Nasr, M., Ghorab, M. K., & Abdelazem, A. (2020). Proniosomes as a drug carrier for transdermal delivery of ketoprofen: Formulation, evaluation, and in vivo studies. AAPS PharmSciTech, 21(3), 109. https://doi.org/10.1208/s12249-020-01660-w
Sharma, A., Choudhury, H., Pandey, M., Reddy, B. R., Gorain, B., & Kesharwani, P. (2021). Intranasal mucoadhesive niosomes for brain targeting: A comprehensive review. Journal of Drug Delivery Science and Technology, 61, 102146. https://doi.org/10.1016/j.jddst.2021.102146
Singh, D., Bhatnagar, P., & Mishra, S. K. (2017). Magnetically responsive niosomes: An emerging platform for targeted drug delivery. Nanomedicine, 12(12), 1345-1360. https://doi.org/10.2217/nnm-2016-0445.
Abo El-Enin, H. A., Allam, A. N., El-Badry, M., & El-Sayed, M. M. H. (2023). Chitosan-coated niosomes for nose-to-brain delivery of clonazepam: Formulation, stability, and permeability studies. Journal of Drug Delivery Science and Technology, 79, 104004.ScienceDirect+2ResearchGate+2PMC+2
Kaur, H., & Garg, T. (2023). Unraveling the role of chitosan for nasal drug delivery systems: A review. Journal of Drug Delivery Science and Technology, 77, 103995.ResearchGate+1ScienceDirect+1
Rinaldi, F., Hanieh, P. N., Longhi, C., Carradori, S., & Marianecci, C. (2018). Chitosan glutamate-coated niosomes: A proposal for nose-to-brain delivery. Pharmaceutics, 10(2), 38.Semantic Scholar
de Souza, F. C., de Oliveira, M. C., & de Paula, E. (2023). Optimization of chitosan-coated niosomes encapsulating doxorubicin: A strategy for enhanced drug delivery. Industrial & Engineering Chemistry Research, 62(7), 3104–3116.
Dhaliwal, H. K., Fan, Y., Kim, J., & Amiji, M. M. (2021). Intranasal delivery and transfection of mRNA therapeutics in the brain using cationic liposomes. Molecular Pharmaceutics, 18(6), 2237–2248.
Ahmad, N., Alam, M. A., Ahmad, R., & Alam, P. (2022). Chitosan-coated niosomes for nasal drug delivery: A promising approach. International Journal of Biological Macromolecules, 200, 421-430.
Bhattacharya, S., & Prajapati, S. K. (2021). Role of mucoadhesive polymers in nasal drug delivery: Chitosan-coated niosomes. Drug Delivery and Translational Research, 11(4), 982-995.
Gupta, P., & Sharma, S. (2020). Advances in intranasal drug delivery using chitosan-based nanocarriers. Journal of Controlled Release, 326, 150-167.
Kumar, A., Singh, P., & Verma, D. (2021). Nasal niosomal drug delivery systems: Enhancing bioavailability with chitosan coating. Current Drug Delivery, 18(9), 1205-1217.
Patel, M. R., & Shah, D. A. (2023). Chitosan-coated niosomes: A potential carrier for peptide drug delivery through the nasal route. International Journal of Pharmaceutics, 634, 122629.
Abdelbary, G. A., & Aburahma, M. H. (2015). Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Drug Design, Development and Therapy, 9, 6295–6304. https://pmc.ncbi.nlm.nih.gov/articles/PMC7356232/
Aparajay, P., & Dev, A. (2021). Niosomes for Nose-to-Brain Delivery: A Non-Invasive Versatile Carrier for the Treatment of Neurological Disorders. European Journal of Pharmaceutical Sciences, 159, 105698. https://www.sciencedirect.com/science/article/abs/pii/S1773224723008596
Dhaliwal, H. K., Fan, Y., Kim, J., & Amiji, M. M. (2021). Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes. Molecular Pharmaceutics, 18(6), 2233–2244. https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.1c00241
Katare, Y. K., Daya, R. P., Sookram Gray, C., Luckham, R. E., & Bhandari, J. (2015). Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer. Molecular Pharmaceutics, 12(5), 3380–3388. https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5b00315
Kaur Dhaliwal, H., Fan, Y., Kim, J., & Amiji, M. M. (2020). Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes. Molecular Pharmaceutics, 17(6), 1996–2005. https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.0c00241Wikipedia
Lee, D., & Minko, T. (2021). Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood-Brain Barrier. Pharmaceutics, 13(12), 2049. https://www.mdpi.com/1999-4923/13/12/2049Wikipedia
Mathure, D., & Madan, J. (2019). Formulation and Evaluation of Niosomal In Situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route. Journal of Pharmaceutical Sciences and Research, 11(9), 3220–3227. https://www.semanticscholar.org/paper/Formulation-and-Evaluation-of-Niosomal-in-situ-Gel-Mathure-Madan/3f1fe141a4011fb88b414a1054fe26729dfdc0beSemantic Scholar
Shah, P., Dubey, P., Vyas, B., Kaul, A., & Mishra, A. K. (2021). Lamotrigine Loaded PLGA Nanoparticles Intended for Direct Nose to Brain Delivery in Epilepsy: Pharmacokinetic, Pharmacodynamic and Scintigraphy Study. Artificial Cells, Nanomedicine, and Biotechnology, 49(1), 371–381. https://www.tandfonline.com/doi/full/10.1080/21691401.2021.1879815Wikipedia
Tanaka, A., Furubayashi, T., Arai, M., Inoue, D., & Kimura, S. (2018). Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application. Molecular Pharmaceutics, 15(3), 1106–1115. https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.7b01137Wikipedia
Wang, J. T.-W., Rodrigo, A. C., Patterson, A. K., Hawkins, K., Aly, M. M. S., & others. (2021). Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self-Healing Supramolecular Gel. Advanced Science, 8(14), 2004225. https://onlinelibrary.wiley.com/doi/full/10.1002/advs.202004225
Alkilani, A. Z., & Hamed, R. (2022). Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study. ACS Omega, 7(42), 37984–37996. https://doi.org/10.1021/acsomega.2c03762ACS Publications
Bhardwaj, S., & Bhatia, S. (2020). Development and Characterization of Niosomal Gel System Using Lallementia Royaleana Benth. Mucilage for the Treatment of Rheumatoid Arthritis. Iranian Journal of Pharmaceutical Research, 19(3), 465–482. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757995/ResearchGate
Gugleva, V., Mihaylova, R., Kamenova, K., Zheleva-Dimitrova, D., Stefanova, D., Tzankova, V., Zaharieva, M. M., Najdenski, H., Forys, A., Trzebicka, B., Petrov, P. D., & Momekova, D. (2024). Development and Characterization of Dual-Loaded Niosomal Ion-Sensitive In Situ Gel for Ocular Delivery. Gels, 10(12), 816. https://doi.org/10.3390/gels10120816MDPI
Palak, P., & Kaur, R. (2021). Preparation and Evaluation of Niosomal Gel Loaded with Combination of Tretinoin and Clindamycin for Acne Treatment. Journal of Drug Delivery and Therapeutics, 11(4), 153–161. https://jddtonline.info/index.php/jddt/article/download/6477/5948J drug Delivery & Therapeutics
Shah, P., Dubey, P., Vyas, B., Kaul, A., & Mishra, A. K. (2021). Lamotrigine Loaded PLGA Nanoparticles Intended for Direct Nose to Brain Delivery in Epilepsy: Pharmacokinetic, Pharmacodynamic and Scintigraphy Study. Artificial Cells, Nanomedicine, and Biotechnology, 49(1), 371–381. https://doi.org/10.1080/21691401.2021.1879815
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
